These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9493252)

  • 1. [Preparation and characteristics of antibodies to a sulfur-containing hapten, mimicking the transition state in lactamization reactions].
    Zherdev AV; Dzantiev BB; Popov VO; Dzantiev LB; Kirby AJ; Sviridov VV; Iakovleva IV
    Prikl Biokhim Mikrobiol; 1997; 33(6):624-31. PubMed ID: 9493252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and fluorescence studies of affinity maturation in related antibodies.
    Pauyo T; Hilinski GJ; Chiu PT; Hansen DE; Choi YJ; Ratner DI; Shah-Mahoney N; Southern CA; O'Hara PB
    Mol Immunol; 2006 Mar; 43(7):812-21. PubMed ID: 16137768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies.
    Shimizu T; Osaka Y; Banri-Koike C; Yoshida M; Endo K; Furukawa K; Oda M; Murakami A; Ogawa S; Abe R; Azuma T
    Int Immunol; 2007 Oct; 19(10):1157-64. PubMed ID: 17881502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies with broad specificity to azaspiracids by use of synthetic haptens.
    Forsyth CJ; Xu J; Nguyen ST; Samdal IA; Briggs LR; Rundberget T; Sandvik M; Miles CO
    J Am Chem Soc; 2006 Nov; 128(47):15114-6. PubMed ID: 17117862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological optimization of a generic hydrophobic pocket for high affinity hapten binding and Diels-Alder activity.
    Piatesi A; Hilvert D
    Chembiochem; 2004 Apr; 5(4):460-6. PubMed ID: 15185369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different hapten-carrier conjugation ratios and molecular orientations on antibody affinity against a peptide antigen.
    Pedersen MK; Sorensen NS; Heegaard PM; Beyer NH; Bruun L
    J Immunol Methods; 2006 Apr; 311(1-2):198-206. PubMed ID: 16574142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dependence of properties of polyclonal antibodies to (2'-5')-oligoadenylates on the method of hapten binding to an immunogen].
    Kulak TI; Kvasiuk EI; Sentiureva SL; Shuliakovskaia SM; Matiushevskaia VP; Makarenko MV; Mikhaĭlopulo IA
    Bioorg Khim; 1999 Sep; 25(9):679-89. PubMed ID: 10624560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
    Nishi Y; Yamamoto N; Shimazaki K; Takahashi-Ando N; Kakinuma H; Jialin S; Ruzheinikov SN; Muranova TA; Rice DW; Kajihara Y
    J Biochem; 2007 Oct; 142(4):421-33. PubMed ID: 17981825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forchlorfenuron-mimicking haptens: from immunogen design to antibody characterization by hierarchical clustering analysis.
    Suárez-Pantaleón C; Mercader JV; Agulló C; Abad-Somovilla A; Abad-Fuentes A
    Org Biomol Chem; 2011 Jul; 9(13):4863-72. PubMed ID: 21562652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of carrier and hapten array on the production of anti-hapten antibodies analyzed by two-dimensional affinity electrophoresis.
    Wang P; Nakamura K
    Electrophoresis; 1998 Jun; 19(8-9):1506-10. PubMed ID: 9694303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A focused antibody library for improved hapten recognition.
    Persson H; Lantto J; Ohlin M
    J Mol Biol; 2006 Mar; 357(2):607-20. PubMed ID: 16445941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the specificity of anti-hapten antibody].
    Kitagawa T
    Tanpakushitsu Kakusan Koso; 1987 Sep; (31 Suppl):211-8. PubMed ID: 2827236
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody production: Low dose immunogen vs. low incorporation hapten using salmeterol as a model.
    Fodey TL; Greer NM; Crooks SR
    Anal Chim Acta; 2009 Apr; 637(1-2):328-32. PubMed ID: 19286047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squaric monoamide monoester as a new class of reactive immunization hapten for catalytic antibodies.
    Xu Y; Yamamoto N; Ruiz DI; Kubitz DS; Janda KD
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4304-7. PubMed ID: 16046128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of covalent binding antibodies.
    Armentano F; Knight T; Makker S; Tramontano A
    Immunol Lett; 2006 Feb; 103(1):51-7. PubMed ID: 16297987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of hapten-protein conjugates for antibody production against small molecules.
    Singh KV; Kaur J; Varshney GC; Raje M; Suri CR
    Bioconjug Chem; 2004; 15(1):168-73. PubMed ID: 14733597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of peptide mimotopes for the fluorescein hapten binding of monoclonal antibody B13-DE1.
    Böttger V; Peters L; Micheel B
    J Mol Recognit; 1999; 12(3):191-7. PubMed ID: 10398409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.